Solna, Sweden · Founded 2017 · Privately Held (backing)
Developer a metabolism-based liquid biopsy platform designed to prevent cancer mortality through earlier detection and closer monitoring. Elypta is based in Solna, Sweden and was founded in 2017. It has raised $29.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$29.8M
Last round
—
Team — not yet on record
No current team members for Elypta are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Elypta with a free account
·The complete investor list: 17 names
·Watch Elypta: the Monday email on marks, rounds and moves
